+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Protein Degraders - Pipeline Insight, 2025 - Product Thumbnail Image

Protein Degraders - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Refractive Errors - Pipeline Insight, 2025 - Product Thumbnail Image

Refractive Errors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Renal Impairment - Pipeline Insight, 2025 - Product Thumbnail Image

Renal Impairment - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Rotator Cuff Injuries - Pipeline Insight, 2025 - Product Thumbnail Image

Rotator Cuff Injuries - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
SCN2A Developmental And Epileptic Encephalopathy (SCN2A - Pipeline Insight, 2025 - Product Thumbnail Image

SCN2A Developmental And Epileptic Encephalopathy (SCN2A - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Surgical Bleeding - Pipeline Insight, 2025 - Product Thumbnail Image

Surgical Bleeding - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Treg Cell-Based Therapies - Pipeline Insight, 2025 - Product Thumbnail Image

Treg Cell-Based Therapies - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Uremic Pruritus And Associated Dry Skin - Pipeline Insight, 2025 - Product Thumbnail Image

Uremic Pruritus And Associated Dry Skin - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Vascular Anomalies- Pipeline Insight, 2025 - Product Thumbnail Image

Vascular Anomalies- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Von Hippel-Lindau Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Von Hippel-Lindau Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Post-transplant Lymphoproliferative Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Post-transplant Lymphoproliferative Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Adrenal Crisis - Pipeline Insight, 2025 - Product Thumbnail Image

Adrenal Crisis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Craniopharyngioma - Pipeline Insight, 2025 - Product Thumbnail Image

Craniopharyngioma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
5-HT1 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT1 Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
5-HT2 Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT2 Agonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
5-HT4 Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT4 Agonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 120 Pages
  • Global
From
5-HT4 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT4 Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Vascular Endothelial Growth Factor Receptor 3 Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Vascular Endothelial Growth Factor Receptor 3 Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Complement Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 150 Pages
  • Global
From
Recurrent Clostridioides Difficile Infection (rCDI) - Pipeline Insight, 2025 - Product Thumbnail Image

Recurrent Clostridioides Difficile Infection (rCDI) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more